Abstract
Drug eluting stents (DES) with biodegradable polymer (BD) were developed in comparison to durable polymers (DP) to improve clinical outcomes in coronary artery disease. However, Results reported by multiple randomized controlled trials (RCTs) remain controversial.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the Society for Cardiovascular Angiography & Interventions
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
